Pasar al contenido principal

RADIOGENOMICA PARA LA MEDICINA PERSONALIZADA EN LA ENFERMEDAD PULMONAR OBSTRUCTIVA CRONICA

PID2021-122855OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Federated privacy-protected meta- and mega-omics data analysis in multi-center studies with a fully open-source analytic platform

  • Escribà Montagut, Xavier
  • Marcon, Yannick
  • Anguita Ruiz, Augusto
  • Avraam, Demetris
  • Urquiza, José M.
  • Morgan, Andrei S.
  • Wilson, Rebecca C.
  • Burton, Paul
  • González, Juan Ramón
The importance of maintaining data privacy and complying with regulatory requirements is highlighted especially when sharing omic data between different research centers. This challenge is even more pronounced in the scenario where a multi-center effort for collaborative omics studies is necessary. OmicSHIELD is introduced as an open-source tool aimed at overcoming these challenges by enabling privacy-protected federated analysis of sensitive omic data. In order to ensure this, multiple security mechanisms have been included in the software. This innovative tool is capable of managing a wide range of omic data analyses specifically tailored to biomedical research. These include genome and epigenome wide association studies and differential gene expression analyses. OmicSHIELD is designed to support both meta- and mega-analysis, so that it offers a wide range of capabilities for different analysis designs. We present a series of use cases illustrating some examples of how the software addresses real-world analyses of omic data., This research has received funding from the Spanish Ministry of Education, Innovation and Universities, the National Agency for Research and the Fund for Regional Development (PID2021-122855OB-I00). We also acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/ 10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program and the Consolidated Group on HEALTH ANALYTICS (2021 SGR 01563). This project has also been partially funded from the “Complementary Plan for Biotechnology Applied to Health,” coordinated by the Institut de Bioenginyeria de Catalunya (IBEC) within the framework of the Recovery, Transformation, and Resilience Plan (C17.I1) - Funded by the European Union - NextGenerationEU. We also thank CINECA project (EC H2020 grant 825775) for making synthetic GWAS data available through EGA repository. JU is supported by Catalan program PERIS (Ref.: SLT017/20/000119), granted by Departament de Salut de la Generalitat de Catalunya (Spain). We also thank EUCAN-Connect project (A federated FAIR platform enabling large-scale analysis of high-value cohort data connecting Europe and Canada in personalized health) funded by the European Commission H2020 Flagship Collaboration with Canada (No 824989), the ATHLETE project (Advancing Tools for Human Early Lifecourse Exposome Research and Translation) funded by the European Commission Horizon 2020 research and innovation programme (No 874583) and UKRI Innovation Fellowship with Health Data Research UK [MR/S003959/1].
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Green space exposure and blood DNA methylation at birth and in childhood - A multi-cohort study

  • Aguilar Lacasaña, Sofía
  • Castro, Montserrat de
  • Dadvand, Payam
  • Escribà Montagut, Xavier
  • Fossati, Serena
  • González, Juan Ramón
  • Nieuwenhuijsen, Mark J.
  • Vrijheid, Martine
  • Bustamante Pineda, Mariona
Green space exposure has been associated with improved mental, physical and general health. However, the underlying biological mechanisms remain largely unknown. The aim of this study was to investigate the association between green space exposure and cord and child blood DNA methylation. Data from eight European birth cohorts with a total of 2,988 newborns and 1,849 children were used. Two indicators of residential green space exposure were assessed: (i) surrounding greenness (satellite-based Normalized Difference Vegetation Index (NDVI) in buffers of 100 m and 300 m) and (ii) proximity to green space (having a green space ≥ 5,000 m2 within a distance of 300 m). For these indicators we assessed two exposure windows: (i) pregnancy, and (ii) the period from pregnancy to child blood DNA methylation assessment, named as cumulative exposure. DNA methylation was measured with the Illumina 450K or EPIC arrays. To identify differentially methylated positions (DMPs) we fitted robust linear regression models between pregnancy green space exposure and cord blood DNA methylation and between cumulative green space exposure and child blood DNA methylation. Two sensitivity analyses were conducted: (i) without adjusting for cellular composition, and (ii) adjusting for air pollution. Cohort results were combined through fixed-effect inverse variance weighted meta-analyses. Differentially methylated regions (DMRs) were identified from meta-analysed results using the Enmix-combp and DMRcate methods. There was no statistical evidence of pregnancy or cumulative exposures associating with any DMP (False Discovery Rate, FDR, p-value < 0.05). However, surrounding greenness exposure was inversely associated with four DMRs (three in cord blood and one in child blood) annotated to ADAMTS2, KCNQ1DN, SLC6A12 and SDK1 genes. Results did not change substantially in the sensitivity analyses. Overall, we found little evidence of the association between green space exposure and blood DNA methylation. Although we identified associations between surrounding greenness exposure with four DMRs, these findings require replication., This work was supported by the European Union’s Horizon 2020 research and innovation program − ATHLETE project [grant number 874583], LIFECYCLE project [grant number 733206], LongITools project [grant number 874739] and HELIX project [grant number 308333]. Sofía Aguilar-Lacasaña was funded by the FI-AGAUR Predoctoral contract [2023 FI-2 00797]. ISGlobal acknowledges support from the Spanish Ministry of Science and Innovation and State Research Agency through the “Centro de Excelencia Severo Ochoa 2019–2023” Program [CEX2018-000806-S] and Fondo Europeo de Desarrollo Regional, UE [PID2021-122855OB-I00], and support from the Generalitat de Catalunya through the CERCA Program and Ministery of Research and Universities [2021 SGR 01563]. Details of funding for each study and for contributions of individual studies can be found in Appendix B: Supplementary methods. No funders listed here or in Appendix B influenced the study aim, design, analysis or interpretation of results. The results expressed here are those of the authors and not necessarily any listed funder.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

dsOMOP: bridging OMOP CDM and DataSHIELD for secure federated analysis of standardized clinical data

  • Sarrat González, David
  • Escribà Montagut, Xavier
  • Houghtaling, Jared
  • González, Juan R.
Motivation Collaborative clinical research projects face several challenges related to data sharing. The disparity between data standards and strict privacy regulations become more relevant as the number of involved institutions increases. To address these challenges, the scientific community has progressively adopted common data models like the Observational Medical Outcomes Partnership Common Data Model (OMOP CDM) for multicenter data standardization and implemented federated data analysis platforms like DataSHIELD to perform remote analyses without transferring individual-level data between centers, thus mitigating disclosure risks. However, there is no native implementation that automatically combines both solutions, revealing the need for a tool that enables interoperability between these systems. Results We present dsOMOP, a collection of DataSHIELD packages that facilitates automated extraction and transformation of OMOP CDM data into DataSHIELD-compatible datasets, enabling disclosure-controlled federated analyses of standardized clinical data. dsOMOP allows research institutions to provide access to their data for collaborative projects in a format that is interoperable with the project’s available data, thus facilitating the analysis of large-scale, multicenter clinical data. It incorporates OMOP data directly into the DataSHIELD workflow, where all analyses occur entirely in a federated environment subject to rigorous disclosure controls, ensuring that only aggregated, non-disclosive results are ever returned to analysts., This work was supported by the Spanish Ministry of Education, Innovation and Universities, the National Agency for Research, and the Fund for Regional Development (PID2021-122855OB-I00). We also acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/ 10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program and the Consolidated Group on HEALTH ANALYTICS (2021 SGR 01563). Additionally, this project has received funding from the Instituto de Salud Carlos III (ISCIII) through the project “PMP21/00090,” co-funded by the European Union’s Resilience and Recovery Facility. It has also been partially funded by the “Complementary Plan for Biotechnology Applied to Health,” coordinated by the Institut de Bioenginyeria de Catalunya (IBEC) within the framework of the Recovery, Transformation, and Resilience Plan (C17.I1) – Funded by the European Union—NextGenerationEU.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

dsOMOP: bridging OMOP CDM and DataSHIELD for secure federated analysis of standardized clinical data

  • Sarrat González, David
  • Escribà Montagut, Xavier
  • Houghtaling, Jared
  • González, Juan R.
Motivation Collaborative clinical research projects face several challenges related to data sharing. The disparity between data standards and strict privacy regulations become more relevant as the number of involved institutions increases. To address these challenges, the scientific community has progressively adopted common data models like the Observational Medical Outcomes Partnership Common Data Model (OMOP CDM) for multicenter data standardization and implemented federated data analysis platforms like DataSHIELD to perform remote analyses without transferring individual-level data between centers, thus mitigating disclosure risks. However, there is no native implementation that automatically combines both solutions, revealing the need for a tool that enables interoperability between these systems. Results We present dsOMOP, a collection of DataSHIELD packages that facilitates automated extraction and transformation of OMOP CDM data into DataSHIELD-compatible datasets, enabling disclosure-controlled federated analyses of standardized clinical data. dsOMOP allows research institutions to provide access to their data for collaborative projects in a format that is interoperable with the project’s available data, thus facilitating the analysis of large-scale, multicenter clinical data. It incorporates OMOP data directly into the DataSHIELD workflow, where all analyses occur entirely in a federated environment subject to rigorous disclosure controls, ensuring that only aggregated, non-disclosive results are ever returned to analysts., This work was supported by the Spanish Ministry of Education, Innovation and Universities, the National Agency for Research, and the Fund for Regional Development (PID2021-122855OB-I00). We also acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/ 10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program and the Consolidated Group on HEALTH ANALYTICS (2021 SGR 01563). Additionally, this project has received funding from the Instituto de Salud Carlos III (ISCIII) through the project “PMP21/00090,” co-funded by the European Union’s Resilience and Recovery Facility. It has also been partially funded by the “Complementary Plan for Biotechnology Applied to Health,” coordinated by the Institut de Bioenginyeria de Catalunya (IBEC) within the framework of the Recovery, Transformation, and Resilience Plan (C17.I1) – Funded by the European Union—NextGenerationEU.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Federated privacy-protected meta- and mega-omics data analysis in multi-center studies with a fully open-source analytic platform

  • Escribà Montagut, Xavier
  • Marcon, Yannick
  • Anguita Ruiz, Augusto
  • Avraam, Demetris
  • Urquiza, José M.
  • Morgan, Andrei S.
  • Wilson, Rebecca C.
  • Burton, Paul
  • González, Juan Ramón
The importance of maintaining data privacy and complying with regulatory requirements is highlighted especially when sharing omic data between different research centers. This challenge is even more pronounced in the scenario where a multi-center effort for collaborative omics studies is necessary. OmicSHIELD is introduced as an open-source tool aimed at overcoming these challenges by enabling privacy-protected federated analysis of sensitive omic data. In order to ensure this, multiple security mechanisms have been included in the software. This innovative tool is capable of managing a wide range of omic data analyses specifically tailored to biomedical research. These include genome and epigenome wide association studies and differential gene expression analyses. OmicSHIELD is designed to support both meta- and mega-analysis, so that it offers a wide range of capabilities for different analysis designs. We present a series of use cases illustrating some examples of how the software addresses real-world analyses of omic data., This research has received funding from the Spanish Ministry of Education, Innovation and Universities, the National Agency for Research and the Fund for Regional Development (PID2021-122855OB-I00). We also acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/ 10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program and the Consolidated Group on HEALTH ANALYTICS (2021 SGR 01563). This project has also been partially funded from the “Complementary Plan for Biotechnology Applied to Health,” coordinated by the Institut de Bioenginyeria de Catalunya (IBEC) within the framework of the Recovery, Transformation, and Resilience Plan (C17.I1) - Funded by the European Union - NextGenerationEU. We also thank CINECA project (EC H2020 grant 825775) for making synthetic GWAS data available through EGA repository. JU is supported by Catalan program PERIS (Ref.: SLT017/20/000119), granted by Departament de Salut de la Generalitat de Catalunya (Spain). We also thank EUCAN-Connect project (A federated FAIR platform enabling large-scale analysis of high-value cohort data connecting Europe and Canada in personalized health) funded by the European Commission H2020 Flagship Collaboration with Canada (No 824989), the ATHLETE project (Advancing Tools for Human Early Lifecourse Exposome Research and Translation) funded by the European Commission Horizon 2020 research and innovation programme (No 874583) and UKRI Innovation Fellowship with Health Data Research UK [MR/S003959/1].
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Green space exposure and blood DNA methylation at birth and in childhood - A multi-cohort study

  • Aguilar Lacasaña, Sofía
  • Castro, Montserrat de
  • Dadvand, Payam
  • Escribà Montagut, Xavier
  • Fossati, Serena
  • González, Juan Ramón
  • Nieuwenhuijsen, Mark
  • Vrijheid, Martine
  • Bustamante Pineda, Mariona
Green space exposure has been associated with improved mental, physical and general health. However, the underlying biological mechanisms remain largely unknown. The aim of this study was to investigate the association between green space exposure and cord and child blood DNA methylation. Data from eight European birth cohorts with a total of 2,988 newborns and 1,849 children were used. Two indicators of residential green space exposure were assessed: (i) surrounding greenness (satellite-based Normalized Difference Vegetation Index (NDVI) in buffers of 100 m and 300 m) and (ii) proximity to green space (having a green space ≥ 5,000 m2 within a distance of 300 m). For these indicators we assessed two exposure windows: (i) pregnancy, and (ii) the period from pregnancy to child blood DNA methylation assessment, named as cumulative exposure. DNA methylation was measured with the Illumina 450K or EPIC arrays. To identify differentially methylated positions (DMPs) we fitted robust linear regression models between pregnancy green space exposure and cord blood DNA methylation and between cumulative green space exposure and child blood DNA methylation. Two sensitivity analyses were conducted: (i) without adjusting for cellular composition, and (ii) adjusting for air pollution. Cohort results were combined through fixed-effect inverse variance weighted meta-analyses. Differentially methylated regions (DMRs) were identified from meta-analysed results using the Enmix-combp and DMRcate methods. There was no statistical evidence of pregnancy or cumulative exposures associating with any DMP (False Discovery Rate, FDR, p-value < 0.05). However, surrounding greenness exposure was inversely associated with four DMRs (three in cord blood and one in child blood) annotated to ADAMTS2, KCNQ1DN, SLC6A12 and SDK1 genes. Results did not change substantially in the sensitivity analyses. Overall, we found little evidence of the association between green space exposure and blood DNA methylation. Although we identified associations between surrounding greenness exposure with four DMRs, these findings require replication., This work was supported by the European Union’s Horizon 2020 research and innovation program − ATHLETE project [grant number 874583], LIFECYCLE project [grant number 733206], LongITools project [grant number 874739] and HELIX project [grant number 308333]. Sofía Aguilar-Lacasaña was funded by the FI-AGAUR Predoctoral contract [2023 FI-2 00797]. ISGlobal acknowledges support from the Spanish Ministry of Science and Innovation and State Research Agency through the “Centro de Excelencia Severo Ochoa 2019–2023” Program [CEX2018-000806-S] and Fondo Europeo de Desarrollo Regional, UE [PID2021-122855OB-I00], and support from the Generalitat de Catalunya through the CERCA Program and Ministery of Research and Universities [2021 SGR 01563]. Details of funding for each study and for contributions of individual studies can be found in Appendix B: Supplementary methods. No funders listed here or in Appendix B influenced the study aim, design, analysis or interpretation of results. The results expressed here are those of the authors and not necessarily any listed funder.